This inventor holds 1 USPTO granted patent. Top assignee: Ibcc Holding as. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Anne Pink - Innovator in Angiogenesis Inhibition
Introduction
Anne Pink is a notable inventor based in Tallinn, Estonia. She has made significant contributions to the field of medical treatment through her innovative research and patents. Her work focuses on methods to inhibit angiogenesis and endothelial cell proliferation, which are crucial in various medical conditions.
Latest Patents
Anne Pink holds a patent for "Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation." This invention relates to a method of treatment for conditions associated with the inhibition of angiogenesis and endothelial cell proliferation. The method involves administering an effective amount of vimentin or its derivatives or fragments to a subject in need. Additionally, the invention includes a pharmaceutical composition and a medicament comprising vimentin, as well as its use in the manufacture of a medicament. This innovation allows for the control of angiogenesis and endothelial cell proliferation, providing therapeutic treatment for related conditions.
Career Highlights
Anne Pink is currently associated with Ibcc Holding, where she continues her research and development efforts. Her work has garnered attention in the medical community, highlighting her role as a leading inventor in her field.
Collaborations
Anne collaborates with notable colleagues, including Taavi Pall and Priit Kogerman, who contribute to her research initiatives and projects.
Conclusion
Anne Pink's innovative work in the field of angiogenesis inhibition showcases her dedication to advancing medical treatments. Her contributions are vital for developing effective therapies for conditions related to endothelial cell proliferation.